abstract: false
label: SARS-CoV-2 VLP Vaccine
comment: COVID-19 vaccine, VLP, recombinant spike protein, expressed protein of SARS-CoV-2
  unspecified, with adjuvants (aluminium of unspecified type + CpGODN-K3, a TLR9 agonist)
created: '2021-07-19'
modified: '2023-07-20'
codes:
  NUVACode: '0772'
  SCT_NUVA: '9131002000106'
valences:
- VAL039
